[2-(4-methyl-5,6,7,8-tetrahydro-2-quinazolinyl)ethyl]amine dihydrochloride, 95.0%, 1g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine, 95.0%, 50mg

Colonne capillaire GC ROTI®Cap-35 MS, 30 m, 0,32 mm, 1 Pièce(s)

5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenecarboxylic acid, 98%, 1g

methyl 4-(3,4-difluorophenyl)-6-(methoxymethylidene)-2-oxo-1,3-diazinane-5-carboxylate, 95%, 2g

2-Fluoro-3-methoxypyridine-5-carboxylic acid, 97%, 1g

5-Aminonicotinic acid, 97.0%, 25g

4,4-Dimethylcyclohexanecarboxylic acid, 97%, 250mg

3-acetyl-6-bromo-2H-chromen-2-one, 98.0%, 100g

Ethyl 2-chloro-3-oxopropanoate, 90.0%, 250mg

1-(2-Amino-3-bromophenyl)ethanone, 95.0%, 250mg

tert-Butyl (3-(5-aminonaphthalen-1-yl)propyl)carbamate, 97%, 50mg

3-Bromodibenzo[b,d]furan, 95.0%, 1g